Transaction in Own Shares

Close this window

Transaction in Own Shares

07/07/2026

RNS Number : 1511L

Fevertree Drinks PLC

07 July 2026

7^th July 2026

Fevertree Drinks plc

("Fever-Tree" or the "Company")

Transaction in Own Shares

Fevertree Drinks plc ("Fever-Tree" or the "Company") announces today it has, in accordance with the authority granted by shareholders at its 2025 Annual General Meeting held on 5^th June, purchased the following number of ordinary shares of £0.0025 each in the Company (the "Ordinary Shares") through the Company's broker, Investec Bank plc ("Investec") in the period from 29^th June to 3^rd July 2026.

Date	Venue	Volume-weighted average price (p)	Aggregated volume	Lowest price per share (p)	Highest price per share (p)
29 June 2026	AIMX	804.5000	10,000	804.50	804.50
29 June 2026	XLON	807.3365	32,865	796.00	822.50
30 June 2026	XLON	805.9455	43,111	794.00	816.50
1 July 2026	XLON	812.2709	43,076	799.50	821.50
2 July 2026	XLON	814.8705	37,241	808.50	822.00
3 July 2026	XLON	803.3359	17,781	800.00	811.00

The Company intends to cancel the purchased shares.

Schedule of Purchases - Individual Transactions

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market Abuse Regulation) (which forms part of domestic UK law by virtue of the European Union (Withdrawal) Act 2018, as amended), a full breakdown of the individual trades made by Investec on behalf of the Company as part of the share buyback programme is attached to this announcement.

http://www.rns-pdf.londonstockexchange.com/rns/1511L_1-2026-7-6.pdf

This announcement does not constitute, or form part of, an offer or any solicitation of an offer for securities in any jurisdiction.

For further information please contact:

Investor queries

Steve Nightingale, Director of Investor Relations I steve.nightingale@fever-tree.com I +44 (0)7951 849564

Media queries

Oliver Winters, Director of Communications I oliver.winters@fever-tree.com I +44 (0)770 332 9024

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

POSDQLBBQDLEBBX

Multimedia Files:

Close this window